ArticlePloS one2022

Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement.

Natalie Berghaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.